A Cavendish Square Group publication 47 Key statistics about the Trust Latest research undertaken by the Trust Approximately 4,500 staff serve a local population of 1.1 million people. Over 230 services including inpatient wards, outpatient and community services. The Bethlem Royal Hospital is the oldest psychiatric institution in the world, dating back to its foundation in 1247. The Trust works in partnership with the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King’s College London to host the UK’s only specialist National Institute for Health Research (NIHR) Biomedical Research Centre for mental health and a Biomedical Research Unit for Dementia. The Trust is part of one of England’s six Academic Health Sciences Centres, King’s Health Partners, alongside King’s College London, Guy’s and St Thomas’ and King’s College Hospital NHS Foundation Trusts. Avatar therapy The first large scale study to evaluate avatar therapy for schizophrenia is currently being led by the Trust. The three-year randomised project enables people with schizophrenia to control the voice of their hallucinations. The first results are expected at the start of 2016. Cannabis linked with psychosis The Trust recently led on research which found that 24% of all new cases of psychosis are associated with the use of high potency ‘skunk-like’ cannabis. The findings were based on nearly 800 patients aged 18-65 and they have major implications for prevention of cannabis-associated psychosis. Alzheimer’s research Researchers discovered that repetitive negative thinking, which is a common symptom of many psychological disorders, may increase the risk of developing Alzheimer’s. Until recently, research into Alzheimer’s disease focused on how physical factors were linked to the onset of symptoms. Family therapy for adolescents with anorexia Family therapy for young people with anorexia was trialled by researchers at the Trust in the 1980s and found it was effective for recently diagnosed teenagers still living at home. This led to the development of specialist child and adolescent services. Known as the ‘Maudsley Model’ outside the UK, it is now recommended in clinical guidelines all over the world. Preventing deaths from heroin overdose at home Naloxone is a fast-acting heroin overdose antidote used originally only by the medical profession. It restores consciousness and allows crucial time to seek or dispense medical treatment. In 1996, researchers at the Trust’s National Addiction Centre promoted the idea of ‘take home’ naloxone – a single injection that can be given by friends and family. New treatments for anorexia A number of psychological therapies used in eating disorders services around the world were developed by the Trust. These therapies target personality traits and thinking styles that allow symptoms of anorexia to flourish.
London Mental Health Fact Bbook
To see the actual publication please follow the link above